Company intelligence / Profile preview

Wild Bioscience

Abingdon/Oxford/Milton Park, England, United Kingdomwildbioscience.com ↗

Ownership: Private
Employees: ~25
Development stage: Preclinical

Overview

Wild Bioscience has demonstrated >20% improvements in growth and seed production through enhanced photosynthetic efficiency in initial field trials. The company is currently running its fourth set of global field trials to evaluate performance across different environments and crops. No commercial products yet.

Modalities: Gene editingArtificial intelligence-enabled crop designGenomics-based crop improvement
Industry: Agriculture & AgTech

Beyond the preview

Go deeper on Wild Bioscience.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Wild Bioscience.

Explore the full profile